Login
Navigate Fool.com
Will AGEN beat
the market?

Agenus, Inc. (NASDAQ: AGEN)

Community Rating: 3 Stars: Appealing

3.24 -0.15 (-4.42%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.33
Previous Close $3.39
Daily Range $3.12 - $3.35
52-Week Range $2.27 - $5.27
Market Cap $201.6M
P/E Ratio -4.35
Dividend (Yield) $0.00 (0.0%)
Volume 936,017
Average Daily Volume 1,456,393
Current FY EPS -$0.35

How do you think AGEN
will perform against the market?

Top AGEN Bull/Bear Pitches

 

s2dbaker (< 20)
Submitted October 15, 2013

Sparks of hope in revenue numbers make this a purely speculative choice. Here's to rolling the dice.

0 Replies Reply Report this Post
 

Ernbo6 (< 20)
Submitted May 15, 2007

Antigenics Inc. is a biotechnology company developing technologies and products to treat cancers, infectious diseases and autoimmune disorders, primarily based on immunological approaches. Its advance … More

1 Replies Reply Report this Post

News & Commentary Rss Feed

This Week in Biotech: Allergan Three-Peats in a Bad Way While Agenus Impresses

An early FDA approval, an inhaled therapy being turned away by regulators for a third time, and three positive clinical updates are this week's top biotech stories.

Sector Update: Health-Care Shares Higher Pre-Market

Sector Update: Health Care

Why Agenus Inc. Stock Skyrocketed

Agenus soars after releasing survival data on Prophage, its vaccine to treat the most aggressive form of brain cancer. Find out what the future might hold for Agenus and Prophage.

Tuesday’s Top Biotech Stories: CTI BioPharma, Agenus, and Salix Pharmaceuticals

CTI BioPharma, Agenus, and Salix Pharmaceuticals could all post big gains this morning. Here’s why.

Sector Update: Shares Flat Pre-Market; Agenus Soars 21% on Phase 2 Trial

Sector Update: Healthcare

This Week in Biotech: MannKind's "Finally" Moment and Vertex's Breathtaking Data

MannKind receives favorable news from the FDA while Vertex stuns investors. Plus, three additional biotech companies deliver encouraging clinical results.

Why Agenus Inc. Stock Briefly Spiked Higher

Agenus shares rocket higher following positive phase 2 data on HerpV but quickly tumble back to Earth. Find out what investors should be watching going forward.

Biotech Stocks to Watch Today: Agenus, Allergan and Auxilium Pharmaceuticals

Today's top stories in biotech and health care.

See More AGEN News...

Sector

Healthcare

Industry

Drugs

Agenus, Inc. (AGEN) Description

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches. Website: http://www.agenusbio.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks